Bernard Hirschel

发表

The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients

Huldrych F. Günthard, Niko Beerenwinkel, Matthias Cavassini, 2013, PLoS Comput. Biol..

Is autovaccination dead?

Bernard Hirschel, 2003, Research initiative, treatment action : RITA.

Zidovudine versus placebo: a European-Australian collaborative study

Bernard Hirschel, S Kinloch, Luc Perrin, 1994 .

Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy.

Amalio Telenti, Hansjakob Furrer, Manuel Battegay, 2002, AIDS.

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

Matthias Cavassini, Urs Karrer, Hansjakob Furrer, 2006, The Lancet.

Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era

Matthias Cavassini, Hansjakob Furrer, Bernard Hirschel, 2008, AIDS.

Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study

Jim Young, Amalio Telenti, Hansjakob Furrer, 2004, BMJ : British Medical Journal.

Contribution of Genome-Wide Significant Single-Nucleotide Polymorphisms and Antiretroviral Therapy to Dyslipidemia in HIV-Infected Individuals: A Longitudinal Study

Matthias Cavassini, Patrick Taffé, Amalio Telenti, 2009, Circulation. Cardiovascular genetics.

Turnover of CD 4 1 and CD 8 1 T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

Alan S. Perelson, Bernard Hirschel, Sabine Yerly, 1998 .

Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.

Matthias Cavassini, Patrick Taffé, Sebastian Bonhoeffer, 2010, The Journal of infectious diseases.

Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

Matthias Cavassini, Patrick Taffé, Amalio Telenti, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population

Amalio Telenti, Manuel Battegay, Bernard Hirschel, 2003, The Lancet.

Concorde trial of immediate versus deferred zidovudine

Bernard Hirschel, Julio S. G. Montaner, George Davey Smith, 1994, The Lancet.

Supervised interruptions of antiretroviral therapy

Bernard Hirschel, B. Hirschel, S. Deeks, 2002, AIDS.

The Prevalence of Erectile Dysfunction and Its Association with Antiretroviral Therapy in HIV-Infected Men: The Swiss HIV Cohort Study

Matthias Cavassini, Jim Young, Hansjakob Furrer, 2013, Antiviral therapy.

Is it smart to continue to study treatment interruptions?

Bernard Hirschel, B. Hirschel, T. Flanigan, 2009, AIDS.

Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

Alan S. Perelson, Bernard Hirschel, Sabine Yerly, 1998, The Journal of experimental medicine.

Estimating the Net Contribution of Interleukin-28B Variation to Spontaneous Hepatitis C Virus Clearance

Jacques Fellay, Dermot Kelleher, Amalio Telenti, 2011, Hepatology.

Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS.

Bernard Hirschel, Huldrych F Günthard, John Frater, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

Jean-Marie Annoni, Matthias Cavassini, Bernard Hirschel, 2009, AIDS.

Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study.

Matthias Cavassini, Amalio Telenti, Hansjakob Furrer, 2011, The Journal of infectious diseases.

Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

Beda Joos, Huldrych F. Günthard, Matthias Cavassini, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection

Bernard Hirschel, Sabine Yerly, Huldrych F Günthard, 2009, AIDS.

Correlates of Self-Reported Nonadherence to Antiretroviral Therapy in HIV-Infected Patients: The Swiss HIV Cohort Study

Matthias Cavassini, Hansjakob Furrer, Manuel Battegay, 2006, Journal of acquired immune deficiency syndromes.

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Sven Bergmann, Thomas Berg, Zoltán Kutalik, 2010, Gastroenterology.

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Bernard Hirschel, Adriano Lazzarin, B. Hirschel, 2008, The New England journal of medicine.

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

Manuel Battegay, Bernard Hirschel, Pietro Vernazza, 1997, BMJ.

Self-Reported Non-Adherence to Antiretroviral Therapy Repeatedly assessed by Two Questions Predicts Treatment Failure in Virologically Suppressed Patients

Hansjakob Furrer, Manuel Battegay, Bernard Hirschel, 2008, Antiviral therapy.